NU Skin Enterprises, Inc.: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Feb 16, 2023 and accepted by EDGAR at Feb 15, 2023, 20:26 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $2.23bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2022-01-01 to 2022-12-31 | $630.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2022-01-01 to 2022-12-31 | $1.59bn | us-gaap:GrossProfit |
| Research and development | 12 months2022-01-01 to 2022-12-31 | $23.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | $110.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-01-01 to 2022-12-31 | $13.5m | us-gaap:InterestExpense |
| Income tax | 12 months2022-01-01 to 2022-12-31 | −$15.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | $104.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | $2.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | $2.10 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 50,525,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | $108.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $59.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2022-01-01 to 2022-12-31 | $77.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2022-01-01 to 2022-12-31 | $70.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $264.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $759.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $1.82bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $359.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $923.7m | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $377.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-12-31 | $25.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-12-31 | $897.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001140361-23-007348. Last ingested by Listed: Nov 5, 2026, 18:30 ET. Listed shows no prices and gives no investment advice.